Prolactin‐ and testosterone‐induced carboxypeptidase‐D correlates with increased nitrotyrosines and Ki67 in prostate cancer

作者: Lynn N. Thomas , Jennifer Merrimen , David G. Bell , Ricardo Rendon , Catherine K. L. Too

DOI: 10.1002/PROS.23054

关键词:

摘要: BACKGROUND Carboxypeptidase-D (CPD) cleaves C-terminal arginine for conversion to nitric oxide (NO) by synthase (NOS). Prolactin (PRL) and androgens stimulate CPD gene transcription expression, which increases intracellular production of NO promote viability prostate cancer (PCa) cells in vitro. The current study evaluated whether hormonal upregulation PCa cell viabilty vivo, correlating changes expression nitrotyrosine residues (products action) with proliferation marker Ki67 associated proteins during development progression. METHODS Fresh tissues, obtained from 40 men benign prostatic hyperplasia (BPH) or PCa, were flash-frozen at the time surgery used RT-qPCR analysis CPD, androgen receptor (AR), PRL (PRLR), eNOS, levels. Archival paraffin-embedded tissues 113 BPH immunohistochemical (IHC) nitrotyrosines, phospho-Stat5 (for activated PRLR), AR, eNOS/iNOS, Ki67. RESULTS RT-qPCR IHC analyses showed strong AR PRLR malignant prostates. mRNA levels increased ∼threefold compared BPH, corresponded a twofold increase progressive 11.4 ± 2.1% 21.8 ± 3.2% low-grade (P = 0.007), 40.7 ± 4.0% high-grade (P < 0.0001) 50.0 ± 9.5% castration-recurrent (P < 0.0001). Immunostaining nitrotyrosines mirrored these progression. tended co-localize, as did phospho-Stat5. CONCLUSIONS CPD, nitrotyrosine, higher than along phospho-Stat5. correlation combined abundant PRLR, supports vitro evidence that CPD-Arg-NO pathway is involved regulation proliferation. It further highlights role progression PCa. Prostate 75:1726–1736, 2015. © 2015 Wiley Periodicals, Inc.

参考文章(70)
T. L. M. Pasha, J. E. Tomaszewski, K. T. Montone, C. V. Clevenger, Wan-Ping Chang, Winnie Ngo, Expression of prolactin and prolactin receptor in human breast carcinoma. Evidence for an autocrine/paracrine loop. American Journal of Pathology. ,vol. 146, pp. 695- 705 ,(1995)
Lindy L. Thomsen, David W. Miles, Role of nitric oxide in tumour progression: lessons from human tumours. Cancer and Metastasis Reviews. ,vol. 17, pp. 107- 118 ,(1998) , 10.1023/A:1005912906436
Lucila Sackmann-Sala, Vincent Goffin, Prolactin-Induced Prostate Tumorigenesis Advances in Experimental Medicine and Biology. ,vol. 846, pp. 221- 242 ,(2015) , 10.1007/978-3-319-12114-7_10
Donald J. Tindall, Haojie Huang, Lucy J. Schmidt, Ofelia L. Zegarra-Moro, Disruption of androgen receptor function inhibits proliferation of androgen-refractory prostate cancer cells. Cancer Research. ,vol. 62, pp. 1008- 1013 ,(2002)
Stefan Ambs, Mofolusara O. Ogunfusika, Emanuela Felley-Bosco, William P. Bennett, Curtis C. Harris, William G. Merriam, Peter G. Shields, Timothy R. Billiar, Shawn Klein, Sean M. Oser, Frequent Nitric Oxide Synthase-2 Expression in Human Colon Adenomas: Implication for Tumor Angiogenesis and Colon Cancer Progression Cancer Research. ,vol. 58, pp. 334- 341 ,(1998)
Tao Jin, Jie Fu, Xiao-Jun Feng, Shou-Mei Wang, Xue Huang, Ming-Hua Zhu, Shu-Hui Zhang, SiRNA‐targeted carboxypeptidase D inhibits hepatocellular carcinoma growth Cell Biology International. ,vol. 37, pp. 929- 939 ,(2013) , 10.1002/CBIN.10113
Lynn N. Thomas, Jennifer Merrimen, David G. Bell, Ricardo Rendon, Vincent Goffin, Catherine K. L. Too, Carboxypeptidase-D is elevated in prostate cancer and its anti-apoptotic activity is abolished by combined androgen and prolactin receptor targeting The Prostate. ,vol. 74, pp. 732- 742 ,(2014) , 10.1002/PROS.22793
Fulong TAN, Michael REHLI, Stefan W. KRAUSE, Randal A. SKIDGEL, Sequence of human carboxypeptidase D reveals it to be a member of the regulatory carboxypeptidase family with three tandem active site domains. Biochemical Journal. ,vol. 327, pp. 81- 87 ,(1997) , 10.1042/BJ3270081
J. S. Beckman, W. H. Koppenol, Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. American Journal of Physiology-cell Physiology. ,vol. 271, ,(1996) , 10.1152/AJPCELL.1996.271.5.C1424